£51.33

Humana Recombinant Antibodies for Cancer Therapy - Volume 207

Name: Humana Recombinant Antibodies for Cancer Therapy - Volume 207
Brand: Humana
Price: 51.33 GBP
Availability: InStock

Oncology

It has never been this cheap. We have no record of a lower price.

£51 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 40 days · 40 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 40 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £53 (15 days, 37.5%)

Price range: £51 - £54

Price levels: 4 different prices over 40 days

Description

Explore the advancement of therapeutic agents in Recombinant Antibodies for Cancer Therapy: Methods and Protocols. This volume, part of the Methods in Molecular Biology series, addresses the evolution of antibody technology in clinical settings. While hybridoma technology introduced many potent agents, their use in humans often faced challenges like the development of human antimouse antibodies (HAMA), which can cause allergic reactions and rapid neutralization of the protein. This text examines how recombinant antibody technology provides a way to circumvent these limitations. By tailoring new antibodies through recombinant methods, researchers can move past the constraints of foreign murine proteins. The book covers the potential of these new therapies, supported by initial clinical data that shows encouraging results. It serves as a technical resource for understanding how recombinant methods are shaping the future of oncology and therapeutic antibody development.

Key Features

Addresses the limitations of traditional hybridoma technology and the development of human antimouse antibodies (HAMA) in patients.

Provides information on how recombinant antibody technology is used to tailor new antibodies for clinical use.

Discusses the potential of new therapeutic agents based on initial clinical data and encouraging results.

Part of the recognized Methods in Molecular Biology series, specifically volume 207.

Explores methods to prevent allergic reactions and rapid neutralization caused by foreign murine proteins.

Product Specifications

Brand: Humana
Format: hardcover
ASIN: 0896039188
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 16 September 2002
Listed Since: 28 December 2006

Barcode

No barcode data available

Humana Recombinant Antibodies for Cancer Therapy - Volume 207

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Diagnostic and Therapeutic Antibodies: 40 (Methods in Molecular Medicine, 40)

Recombinant Antibodies for Immunotherapy

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Antibody Engineering Volume 2

Human Monoclonal Antibodies: Methods and Protocols: 1060 (Methods in Molecular Biology, 1060)

Humana Antibody Engineering: Methods and Protocols 1827

Humana Antibody-Drug Conjugates and Immunotoxins Book

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Development of Antibody-Based Therapeutics: Translational Considerations & Challenges

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Antibody Engineering: Methods and Protocols: 248 (Methods in Molecular Biology, 248)

Natural Antibodies: Methods and Protocols: 1643 (Methods in Molecular Biology, 1643)

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)

Humana Therapeutic Antibodies: Methods and Protocols 2313

Peptide Antibodies: Methods and Protocols: 1348 (Methods in Molecular Biology, 1348)

Humana Antibody Methods and Protocols: 901 (Methods in Molecular Biology)

Therapeutic Antibodies: Methods and Protocols: 2313 (Methods in Molecular Biology, 2313)

Humana Antibody Engineering: Methods and Protocols, 2nd Ed

Detection and Quantification of Antibodies to Biopharmaceuticals: Practical and Applied Considerations

Antibodies: Volume 2: Novel Technologies and Therapeutic Use

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)

Development of Antibody-Based Therapeutics: Translational Considerations